Emily Dreyer Sells 7,792 Shares of Trupanion (NASDAQ:TRUP) Stock

Trupanion, Inc. (NASDAQ:TRUPGet Free Report) CRO Emily Dreyer sold 7,792 shares of the stock in a transaction that occurred on Wednesday, March 4th. The shares were sold at an average price of $28.15, for a total value of $219,344.80. Following the transaction, the executive owned 35,627 shares of the company’s stock, valued at approximately $1,002,900.05. This trade represents a 17.95% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

Trupanion Stock Down 4.6%

TRUP stock opened at $27.44 on Friday. The company has a current ratio of 1.69, a quick ratio of 1.69 and a debt-to-equity ratio of 0.27. The firm has a 50 day simple moving average of $31.95 and a 200-day simple moving average of $37.86. The company has a market capitalization of $1.19 billion, a P/E ratio of 60.98 and a beta of 1.62. Trupanion, Inc. has a twelve month low of $25.24 and a twelve month high of $57.88.

Trupanion (NASDAQ:TRUPGet Free Report) last posted its quarterly earnings results on Thursday, February 12th. The financial services provider reported $0.13 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.14 by ($0.01). Trupanion had a net margin of 1.35% and a return on equity of 5.39%. The company had revenue of $376.85 million during the quarter, compared to analyst estimates of $375.89 million. During the same period in the prior year, the company earned $0.04 earnings per share. The company’s revenue was up 11.7% on a year-over-year basis. On average, equities research analysts predict that Trupanion, Inc. will post 0.13 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

TRUP has been the topic of a number of recent analyst reports. Piper Sandler cut their target price on shares of Trupanion from $60.00 to $45.00 and set an “overweight” rating on the stock in a research note on Friday, February 13th. Cantor Fitzgerald decreased their price target on Trupanion from $50.00 to $42.00 and set a “neutral” rating for the company in a research note on Wednesday, January 14th. Stifel Nicolaus lowered their price objective on Trupanion from $38.00 to $35.00 and set a “hold” rating for the company in a report on Friday, February 13th. Weiss Ratings cut Trupanion from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Wednesday. Finally, Zacks Research downgraded Trupanion from a “strong-buy” rating to a “hold” rating in a report on Friday, February 13th. Two analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $45.50.

Get Our Latest Analysis on TRUP

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of the business. Federated Hermes Inc. bought a new stake in shares of Trupanion during the 3rd quarter valued at about $33,000. Pilgrim Partners Asia Pte Ltd bought a new position in Trupanion in the third quarter worth about $39,000. Nisa Investment Advisors LLC boosted its stake in Trupanion by 44.1% in the second quarter. Nisa Investment Advisors LLC now owns 980 shares of the financial services provider’s stock valued at $54,000 after acquiring an additional 300 shares during the period. Kelleher Financial Advisors acquired a new position in Trupanion in the third quarter valued at approximately $74,000. Finally, Kemnay Advisory Services Inc. bought a new position in shares of Trupanion during the fourth quarter valued at approximately $64,000.

Trupanion Company Profile

(Get Free Report)

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.

Featured Stories

Insider Buying and Selling by Quarter for Trupanion (NASDAQ:TRUP)

Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.